← Back to screener

RESMED INC RMD

Rank #852 · NYSE · $33.4B market cap
Audited by KPMG LLP, no going-concern flag in the latest filing.
Score
57.5
P/E
32.7
P/B
8.08
ROE
24.7%
Op. Margin
28.2%
Debt Ratio
53%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Average

P/E 32.7x, P/B 8.08x. Ranks in the top 60% of the universe.

Profitability ★★★★☆
Excellent

ROE 24.7%. Ranks in the top 14% of the universe.

Safety ★★★★☆
Good

Debt ratio 53%. Ranks in the top 25% of the universe.

Growth ★★★☆☆
Good

Revenue growth of 10.9% year over year. Ranks in the top 33% of the universe.

Profitability is the relative strength · Valuation is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011–$0.2B$0.1B$1.1B–31
2012–$0.2B$0.2B$1.1B–30
2013–$0.3B$0.2B$1.3B–41
2014$1.4B$0.3B$0.3B$1.7B21.535
2015$1.5B$0.4B$0.3B$1.6B23.437
2016$1.6B$0.4B$0.3B$1.6B26.137
2017$1.7B$0.4B$0.4B$1.8B24.489
2018$1.8B$0.4B$0.4B$1.6B23.395
2019$2.1B$0.4B$0.3B$1.7B20.659
2020$2.3B$0.5B$0.3B$2.0B23.2104
2021$2.6B$0.6B$0.4B$2.1B22.2102
2022$3.0B$0.8B$0.6B$2.1B27.489
2023$3.2B$0.9B$0.5B$2.5B28.369
2024$3.6B$1.0B$0.8B$2.9B28.091
2025$4.2B$1.1B$0.9B$3.4B26.860
2026$4.7B$1.3B$1.0B$4.1B28.253

← See the full screener